Clinical-stage biopharmaceutical company Heat Biologics has broken ground on its new biomanufacturing/bioanalytic facility in San Antonio, the US.
The firm secured approval for an estimated $1m in tax abatements from San Antonio city and Bexar County.
The firm’s completely-owned subsidiary, Scorpion Biological Services, intends to construct a large molecule bioanalytical research and manufacturing facility in San Antonio.
Among the anticipated activities include the development of in-house immuno-assays and biomarkers, a Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) laboratory, and cGMP manufacturing capabilities.
Heat Biologics CEO Jeff Wolf said: “We appreciate the tremendous support from the San Antonio community as we expand our biomanufacturing and bioanalytic capabilities. We expect this facility to shorten our development and manufacturing timelines and reduce costs for these services which we would have otherwise outsourced to third-party contractors. In addition to supporting our own internal operations, we plan to leverage these capabilities to support other biopharma companies.”
San Antonio Mayor Ron Nirenberg said: “Our diverse medical and bioscience community has come together to form an ecosystem that’s cooperative and supportive — one that drives innovation to improve lives — and that’s attractive to startups, established corporations, and talent. We are committed to supporting Scorpion as they grow their operations in our community.”
Image: The firm secured approval for an estimated $1m in tax abatements from San Antonio city and Bexar County. Credit: Michal Jarmoluk from Pixabay